孟晚舟入禀香港法院要求汇丰披露涉案相关文件
华为副董事长兼首席财务官孟晚舟向香港高等法院申请,要求汇丰披露涉及其案件的相关文件。
据法庭文件显示,孟晚舟因美国政府要求引渡的案件,被加拿大法院禁止出境,当中涉及华为被指於2013年误导汇丰银行,处理其与伊朗交易。
华为要求的文件包括由汇丰风险委员会(risk committee)於2012年12月至2015年4月发出,有关评估华为、关连公司Skycom Tech Co Ltd、Skycom Tech Co Ltd母公司Canicula Holdings Ltd.的合规、制裁、信贷、信誉风险有关文件,及评估是否继续与上述3名客户维持关系的相关文件等。
孟晚舟早前曾於英国入禀索取上述文件,惟未能成功。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.